Figure 1.
Daily administration of 3-BP delayed SCC tumor growth. When tumor size became 1.0-1.2 cm (10 days after implantation), 10 mg/kg/day of glycolysis inhibitor 3-BP was intraperitoneally injected into mice bearing SCC tumor on their right leg. The 3-BP significantly suppressed the SCC tumor growth compared to control group of mice treated by PBS as vehicle.